{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:35:11Z","timestamp":1787063711931,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2002,7,31]],"date-time":"2002-07-31T00:00:00Z","timestamp":1028073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,7,31]],"date-time":"2002-07-31T00:00:00Z","timestamp":1028073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2002,8,1]]},"DOI":"10.1038\/sj.leu.2402549","type":"journal-article","created":{"date-parts":[[2002,10,21]],"date-time":"2002-10-21T06:59:36Z","timestamp":1035183576000},"page":"1399-1401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Erythroleukemia: a need for a new definition"],"prefix":"10.1038","volume":"16","author":[{"given":"S","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Dreyfus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,7,31]]},"reference":[{"key":"BF2402549_CR1","volume-title":"Le Malatte Eritremiche ed Eritroleucemiche","author":"G Di Guglielmo","year":"1962","unstructured":"Di Guglielmo G . Le Malatte Eritremiche ed Eritroleucemiche II Pensiero Scientifico: Rome 1962"},{"key":"BF2402549_CR2","doi-asserted-by":"publisher","first-page":"620","DOI":"10.7326\/0003-4819-103-4-620","volume":"103","author":"JM Bennett","year":"1985","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C . 1985 proposed revised criteria for the classification of acute myeloid leukemia. A report of the French\u2013American\u2013British Cooperative Group Ann Intern Med 1985 103: 620\u2013625","journal-title":"Ann Intern Med"},{"key":"BF2402549_CR3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/00000421-199802000-00010","volume":"21","author":"SL Goldberg","year":"1998","unstructured":"Goldberg SL, Noel P, Lumpp TR, Dewald G . The erythroid leukemias. A comparative study of erythroleukemia (FABM6) and Di Guglielmo disease Am J Clin Oncol 1998 21: 42\u201347","journal-title":"Am J Clin Oncol"},{"key":"BF2402549_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1046\/j.1365-2141.1999.01684.x","volume":"107","author":"K Wheatley","year":"1999","unstructured":"Wheatley K, Burnett AK, Goldstone AH, Gray RG, Hann IM, Harrison CJ, Rees JKH, Stevens RF, Walker H . A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukemia derived from the MRC AML10 trial Br J Haematol 1999 107: 69\u201379","journal-title":"Br J Haematol"},{"key":"BF2402549_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/ajh.2830490106","volume":"49","author":"FR Davey","year":"1995","unstructured":"Davey FR, Abraham N, Brunetto VL, MacCallum JM, Nelson DA, Ball ED, Griffin JD, Baer MR, Wurster-Hill D, Mayer RJ, Schiffer CA, Bloomfield CD . Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study Am J Hematol 1995 49: 29\u201338","journal-title":"Am J Hematol"},{"key":"BF2402549_CR6","first-page":"4116","volume":"93","author":"T B\u00fcchner","year":"1999","unstructured":"B\u00fcchner T, Hiddemann W, W\u00f6rmann B, L\u00f6ffler H, Gassmann W, Haferlach T, Fonatsch C, Haase D, Schoch C, Hossfeld D, Lengfelder E, Aul C, Heyll A, Maschmeyer G, Ludwig W-D, Sauerland M-C, Heinecke A . Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the german AML cooperative group Blood 1999 93: 4116\u20134124","journal-title":"Blood"},{"key":"BF2402549_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/1096-8652(200009)65:1<5::AID-AJH2>3.0.CO;2-U","volume":"65","author":"A Kowal-Vern","year":"2000","unstructured":"Kowal-Vern A, Mazzella FM, Cotelingam JD, Shrit A, Rector JT, Schumacher HR . Diagnosis and characterization of acute erythroleukemia subsets by determining the percentages of myeloblasts and proerythroblasts in 69 cases Am J Hematol 2000 65: 5\u201313","journal-title":"Am J Hematol"},{"key":"BF2402549_CR8","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1182\/blood.V80.11.2873.2873","volume":"80","author":"O Olufunmilayo","year":"1992","unstructured":"Olufunmilayo O, Thangavelu M, Larson RA, Mick R, Kowal-Vern A, Schumacher HR, Le Beau MM, Vardiman JW, Rowley JD . Clinical, morphologic and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia Blood 1992 80: 2873\u20132882","journal-title":"Blood"},{"key":"BF2402549_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0272-2712(18)30080-5","volume":"20","author":"F Mazzella","year":"2000","unstructured":"Mazzella F, Alvares C, Kowal-Vern A, Schumacher H . The acute erythroleukemias Clin Lab Med 2000 20: 119\u2013137","journal-title":"Clin Lab Med"},{"key":"BF2402549_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/modpathol.3880070","volume":"13","author":"FM Mazzella","year":"2000","unstructured":"Mazzella FM, Kowal-Vern A, Shrit A, Rector JT, Cotelingam JD, Schumacher HR . Effects of multidrug resistance gene expression in acute erythroleukemia Mod Pathol 2000 13: 407\u2013413","journal-title":"Mod Pathol"},{"key":"BF2402549_CR11","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","volume":"17","author":"NL Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD . World Health Organisation Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: report of the clinical advisory committee meeting; Airlie House, Virginia, November 1997 J Clin Oncol 1999 17: 3835\u20133849","journal-title":"J Clin Oncol"},{"key":"BF2402549_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0145-2126(01)00146-1","volume":"26","author":"S Park","year":"2002","unstructured":"Park S, Picard F, Azgui Z, Vigu\u00e9 F, Merlat A, Guesnu M, Leblond V, Dreyfus F . Erythroleukemia: a comparison between the previous FAB approach and the WHO classification Leukemia Res 2002 26: 423\u2013429","journal-title":"Leukemia Res"},{"key":"BF2402549_CR13","first-page":"34","volume":"98","author":"A Kowal-Vern","year":"1992","unstructured":"Kowal-Vern A, Cotelingam J, Schumacher HR . The prognostic significance of proerythroblasts in acute erythroleukemia Hematopathology 1992 98: 34\u201340","journal-title":"Hematopathology"},{"key":"BF2402549_CR14","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1182\/blood.V93.12.4425","volume":"93","author":"MJ Southcott","year":"1999","unstructured":"Southcott MJ, Tanner MJ, Anstee DJ . The expression of human blood group antigens during erythropoiesis in a cell culture system Blood 1999 93: 4425\u20134435","journal-title":"Blood"},{"key":"BF2402549_CR15","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.1365-2141.1995.tb05208.x","volume":"90","author":"R Garand","year":"1995","unstructured":"Garand R, Duchayne E, Blanchard D, Robillard N, Kuhlein E, Fenneteau O, Salomon-Nguyen F, Grange MJ, Rousselot P, Demur C, Talmant P, Radford I, Flandrin G . Minimally differentiated erythroleukemia (AML6 variant): a rare subset of AML distinct from AML M6 Br J Haematol 1995 90: 868\u2013875","journal-title":"Br J Haematol"},{"key":"BF2402549_CR16","volume-title":"Pathology and genetics of tumours of haematopoietic and lymphoid tissues. WHO Classification of Tumours","author":"ES Jaffe","year":"2001","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman JW . Pathology and genetics of tumours of haematopoietic and lymphoid tissues. WHO Classification of Tumours IARC Press: Lyon 2001"},{"key":"BF2402549_CR17","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0268-960X(92)90016-J","volume":"6","author":"J Atkinson","year":"1993","unstructured":"Atkinson J, Hrisinko MA, Weil SC . Erythroleukemia: a review of 15 cases meeting 1985 FAB criteria and survey of the literature Blood Rev 1993 6: 204\u2013214","journal-title":"Blood Rev"},{"key":"BF2402549_CR18","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1182\/blood.V88.1.358.358","volume":"88","author":"L Sutton","year":"1996","unstructured":"Sutton L, Chastang C, Ribaud P, Jouet JP, Kuentz M, Attal M, Reiffers J, Tigaud JM, Rio B, Dauriac C, Legros M, Dreyfus F, Lioure B, Troussard X, Milpied N, Witz F, Oriol P, Cahn JY, Michallet M, Gluckman E, Ifrah N, Pico JL, Vilmer E, Leblond V . Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long term study of 71 patients. Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Moelle Blood 1996 88: 358\u2013365","journal-title":"Blood"},{"key":"BF2402549_CR19","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/sj.bmt.1700971","volume":"20","author":"KK Ballen","year":"1997","unstructured":"Ballen KK, Gilliland DG, Guinan EC, Hsieh CC, Parsons SK, Rimm IJ, Ferrara JL, Bierer BE, Weinstein HJ, Antin JH . Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia Bone Marrow Transplant 1997 20: 737\u2013743","journal-title":"Bone Marrow Transplant"},{"key":"BF2402549_CR20","first-page":"305","volume":"3","author":"H Nakamura","year":"1989","unstructured":"Nakamura H . Cytogenetic heterogeneity in erythroleukemia defined as M6 by the French\u2013American\u2013British Cooperative Group criteria Leukemia 1989 3: 305\u2013309","journal-title":"Leukemia"},{"key":"BF2402549_CR21","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1365-2141.1990.tb04347.x","volume":"75","author":"A Cuneo","year":"1990","unstructured":"Cuneo A, Van Orshoven A, Michaux JL, Boogaerts M, Louwagie A, Doyen CH, Dalcin P, Faglioli F, Castoldi G, Van den Berghe H . Morphologic, immunologic and cytogenetics studies in erythroleukemia: evidence for a multilineage involvement and identification of two distinct cytogenetic-clinicopathological types Br J Haematol 1990 75: 346\u2013354","journal-title":"Br J Haematol"},{"key":"BF2402549_CR22","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1182\/blood.V98.6.1752","volume":"98","author":"PD Kottaridis","year":"2001","unstructured":"Kottaridis PD, Gale RE, Frew ME, Harrison G, Langabeer SE, Belton AA, Walker H, Wheatley K, Bowen DT, Burnett AK, Goldstone AH, Linch DC . The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials Blood 2001 98: 1752\u20131759","journal-title":"Blood"},{"key":"BF2402549_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/00000421-199802000-00010","volume":"21","author":"SL Goldberg","year":"1998","unstructured":"Goldberg SL, Noel P, Klumpp TR, Dewald GW . The erythroid leukemias. A comparative study of erythroleukemia (FAB M6) and Di Guglielmo disease Am J Clin Oncol 1998 21: 42\u201347","journal-title":"Am J Clin Oncol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2402549.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402549","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402549.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T17:35:27Z","timestamp":1648748127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2402549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,31]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,8,1]]}},"alternative-id":["BF2402549"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2402549","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7,31]]},"assertion":[{"value":"29 October 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}